| Dr Erika Zail Rentas-diaz, MD | |
|
Calle Cielo Dorado 68, Urb Cialo Dorado Village, Dorado, PR 00692-0001 | |
| (787) 638-6541 | |
| Not Available |
| Full Name | Dr Erika Zail Rentas-diaz |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | Calle Cielo Dorado 68, Dorado, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477577096 | NPI | - | NPPES |
| 2011184 | Other | PR | PREFERRED HEALTH |
| 500432E | Other | PR | MEDICARE Y MUCHO MAS |
| 22306 | Other | PR | TRIPLE S |
| 9090175 | Other | PR | HUMANA HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 0015252 (Puerto Rico) | Primary |
| 207P00000X | Emergency Medicine | 15252 (Puerto Rico) | Primary |
| Entity Name | Gemi Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831592781 PECOS PAC ID: 0345568820 Enrollment ID: O20150413001894 |
News Archive
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines for the back of the eye, today announces that it has been awarded a €3 million grant from the Flemish agency for Innovation by Science and Technology.
According to a recent survey conducted by the Waismann Method of opiate detoxification, doctors prescribing medication for the treatment of chronic pain were found to be the leading source of prescription painkiller use. Approximately 88 percent of all respondents stated they began taking prescription painkillers for chronic pain relief, with an astounding 70 percent of these individuals believing that they experience the same or a greater amount of pain than when originally prescribed painkillers.
Glenmark Generics Inc., USA (GGI), the United States subsidiary of Glenmark Generics Limited (GGL), announced they have been granted final approval for their Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (U.S. FDA) for Levocetirizine Dihydrochloride 5 mg tablets, the generic version of UCB Inc.'s Xyzal(R) tablets.
Immune Pharmaceuticals Ltd., a privately held Israeli company, and EpiCept Corporation today announced that they have entered into a definitive merger agreement. The transaction is anticipated to close during the first quarter of 2013 and is subject to satisfaction of certain customary closing conditions, including the approval of a majority of EpiCept shareholders.
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients. Now the discovery of genetic biomarkers relevant to CRC means that targeted personalised medication is increasingly common.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erika Zail Rentas-diaz, MD Calle Cielo Dorado 68, Urb Cialo Dorado Village, Dorado, PR 00692-0001 Ph: (787) 638-6541 | Dr Erika Zail Rentas-diaz, MD Calle Cielo Dorado 68, Urb Cialo Dorado Village, Dorado, PR 00692-0001 Ph: (787) 638-6541 |
News Archive
ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines for the back of the eye, today announces that it has been awarded a €3 million grant from the Flemish agency for Innovation by Science and Technology.
According to a recent survey conducted by the Waismann Method of opiate detoxification, doctors prescribing medication for the treatment of chronic pain were found to be the leading source of prescription painkiller use. Approximately 88 percent of all respondents stated they began taking prescription painkillers for chronic pain relief, with an astounding 70 percent of these individuals believing that they experience the same or a greater amount of pain than when originally prescribed painkillers.
Glenmark Generics Inc., USA (GGI), the United States subsidiary of Glenmark Generics Limited (GGL), announced they have been granted final approval for their Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (U.S. FDA) for Levocetirizine Dihydrochloride 5 mg tablets, the generic version of UCB Inc.'s Xyzal(R) tablets.
Immune Pharmaceuticals Ltd., a privately held Israeli company, and EpiCept Corporation today announced that they have entered into a definitive merger agreement. The transaction is anticipated to close during the first quarter of 2013 and is subject to satisfaction of certain customary closing conditions, including the approval of a majority of EpiCept shareholders.
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients. Now the discovery of genetic biomarkers relevant to CRC means that targeted personalised medication is increasingly common.
› Verified 2 days ago
Dr. Marta Klachko Longo, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 164 Dorado Bch E, Dorado, PR 00646 Phone: 787-796-1971 | |
Carmelo A Crespo, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 338 Calle Mendez Vigo, Dorado, PR 00646 Phone: 787-796-3466 Fax: 787-796-3466 | |
John Ahmed Negron Medina, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Sabanera De Dorado, Camino De Susua, 417, Dorado, PR 00646 Phone: 787-648-0577 | |
Dorayde Quinones-foster, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Calle Rubi, Paseo Real D12, Dorado, PR 00646 Phone: 787-428-5998 |